Post-Marketing Surveillance of Lenvima in Korean Patients
Post-Marketing Surveillance of Lenvima in Korean Patients
The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.
Inclusion criteria:
Participants who meet the following criteria will be eligible for inclusion in the study:
Exclusion Criteria:
Investigators will refer to approved indications and contraindications regarding exclusion criteria
Bundang, Gyeongji-do, South Korea